Spine stereotactic body radiotherapy for renal cell cancer spinal metastases: analysis of outcomes and risk of vertebral compression fracture.

  title={Spine stereotactic body radiotherapy for renal cell cancer spinal metastases: analysis of outcomes and risk of vertebral compression fracture.},
  author={Isabelle Thibault and Ameen Al-Omair and Giuseppina Laura Masucci and Laurence Masson-C{\^o}t{\'e} and Fiona Lochray and Ren{\'e}e Korol and Lu Cheng and Wei Xu and Albert Juang Ming Yee and Michael G. Fehlings and Georg A. Bjarnason and Arjun Sahgal},
  journal={Journal of neurosurgery. Spine},
  volume={21 5},
OBJECT The aim of this study was to evaluate local control (LC) and the risk of vertebral compression fracture (VCF) after stereotactic body radiotherapy (SBRT) in patients with renal cell cancer spinal metastases. METHODS Prospectively collected data on 71 spinal segments treated with SBRT in 37 patients were reviewed. The median follow-up was 12.3 months (range 1.2-55.4 months). The LC rate was assessed based on each spinal segment treated and overall survival (OS) according to each patient… 

Figures and Tables from this paper

Normal Tissue Complication Probability of Vertebral Compression Fracture after Stereotactic Body Radiotherapy for De Novo Spine Metastasis.

  • Xuguang ChenC. Gui K. Redmond
  • Medicine
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
  • 2020

Postoperative Stereotactic Body Radiotherapy for Spinal Metastases and the Impact of Epidural Disease Grade.

The association between downgrading preoperative ED and better local control following pSBRT is confirmed and supports the concept of separation surgery.

Outcomes after reirradiation of spinal metastasis with stereotactic body radiation therapy (SBRT): a retrospective single institutional study

It is demonstrated that reirradiation of spinal metastasis using SBRT provided effective pain relief and neurologic improvement, with minimal toxicity, and was well-tolerated.

Salvage Stereotactic Body Radiotherapy (SBRT) Following In-Field Failure of Initial SBRT for Spinal Metastases.

Dose-escalated two-fraction spine stereotactic body radiotherapy: 28 Gy vs. 24 Gy in 2 daily fractions.

Stereotactic body radiation therapy (SBRT) for metastatic renal cell carcinoma: A multi-institutional experience.

SBRT was well-tolerated with promising LC and both KPS and osseous metastatic disease should be considered in determining which patients with mRCC may preferentially benefit from SBRT.

Spine Stereotactic Body Radiotherapy to Three or More Contiguous Vertebral Levels

For patients with ≥3 contiguous involved levels, spine SBRT is feasible and may offer excellent LC without significant toxicity, and Prospective evaluation is warranted.



Management of spinal metastases from renal cell carcinoma using stereotactic body radiotherapy.

Vertebral compression fracture (VCF) after spine stereotactic body radiation therapy (SBRT): analysis of predictive factors.

Single-fraction stereotactic body radiotherapy for spinal metastases from renal cell carcinoma.

Stereotactic body radiotherapy for RCC metastases to the spine offers fast and durable pain relief with minimal toxicity and seems optimal for patients who have solitary or few spinal metastases.

Surgical resection of epidural disease improves local control following postoperative spine stereotactic body radiotherapy.

Postoperative SBRT with high total doses ranging from 18 to 26 Gy delivered in 1-2 fractions predicted superior LC, as did postoperative epidural grade, and systemic therapy post-SBRT as the only significant predictor of OS.

Stereotactic radiosurgery for spinal metastases from renal cell carcinoma.

Spinal radiosurgery can be a successful therapeutic modality for the delivery of large-dose single-fraction radiation to RCC spinal metastases that are often poorly controlled with conventional EBRT modalities.

Reirradiation human spinal cord tolerance for stereotactic body radiotherapy.

Radiation-induced vertebral compression fracture following spine stereotactic radiosurgery: clinicopathological correlation.

2 patients who were treated with spine SRS who subsequently developed signal changes on MRI consistent with tumor progression and VCF are described; however, biopsy confirmed a diagnosis of radiation-induced necrosis in 1 patient and fibrosis in the other, highlighting the issues in the new era of spine S RS with respect to relying on imaging alone as a means of determining true tumor progression.

Probabilities of radiation myelopathy specific to stereotactic body radiation therapy to guide safe practice.